Casi Pharmaceuticals, Inc logo
VerifiedBiotechnology Research

Casi Pharmaceuticals, Inc

CASI Pharmaceuticals, Inc.(NASDAQ: CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ transplant rejection and autoimmune diseases, today announced FDA clearance of an IND application for CID-103, an anti-CD38 monoclonal antibody in adults with active and chronic active renal allograft antibody mediated rejection (AMR). The Phase 1 clinical trial is a dose-ranging and safety study evaluating the tolerability and efficacy of CID-103 in patients with AMR.

7-day free trial · no credit card

HeadquartersSan Francisco, United StatesEmployees47(51 to 200)Annual revenue$10M to <$50MWebsitecasipharmaceuticals.comLinkedIn profileLinkedIn

Verified contacts

38

available on Kipplo

LinkedIn employees

47

51 to 200 range

Open roles

no listings

Distinct roles

32

indexed titles

Tech stack

1

tools in use

Monthly traffic

1.0K

organic / mo

Sign up free to see all 38 verified contacts at Casi Pharmaceuticals, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

38 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Casi Pharmaceuticals, Inc

32 distinct titles indexed · top 10 shown.

  • 2chief medical officer
  • 1business development manager
  • 1bussiness development manager
  • 1chief commercial officer (cco)
  • 1coo
  • 1dir supply alliance management
  • 1director, supply and manufacturing
  • 1evp, gm of china & global cco
  • 1general manager
  • 1independent director
  • +22more titles

Sign up to unlock all 38 contacts at Casi Pharmaceuticals, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 38 verified contacts at Casi Pharmaceuticals, Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Casi Pharmaceuticals, Inc | Kipplo Discover